The New York Times - Business:
The panel heard strong support from the company and many doctors but concern from F.D.A. scientists.
This post first appeared in The New York Times - Business. Read the original article.
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pill
